SELLAS Life Sciences Group (SLS) EPS (Basic): 2010-2023
Historic EPS (Basic) for SELLAS Life Sciences Group (SLS) over the last 9 years, with Dec 2023 value amounting to -$1.34.
- SELLAS Life Sciences Group's EPS (Basic) rose 41.86% to -$0.25 in Q4 2023 from the same period last year, while for Dec 2023 it was -$1.36, marking a year-over-year increase of 39.01%. This contributed to the annual value of -$1.34 for FY2023, which is 37.09% up from last year.
- SELLAS Life Sciences Group's EPS (Basic) amounted to -$1.34 in FY2023, which was up 37.09% from -$2.13 recorded in FY2022.
- In the past 5 years, SELLAS Life Sciences Group's EPS (Basic) registered a high of -$1.34 during FY2021, and its lowest value of -$10.92 during FY2019.
- In the last 3 years, SELLAS Life Sciences Group's EPS (Basic) had a median value of -$1.34 in 2023 and averaged -$1.60.
- In the last 5 years, SELLAS Life Sciences Group's EPS (Basic) soared by 80.68% in 2020 and then slumped by 58.96% in 2022.
- Yearly analysis of 5 years shows SELLAS Life Sciences Group's EPS (Basic) stood at -$10.92 in 2019, then soared by 80.68% to -$2.11 in 2020, then skyrocketed by 36.49% to -$1.34 in 2021, then plummeted by 58.96% to -$2.13 in 2022, then surged by 37.09% to -$1.34 in 2023.